95 related articles for article (PubMed ID: 22153861)
1. A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats.
Scott VE; Vortherms TA; Niforatos W; Swensen AM; Neelands T; Milicic I; Banfor PN; King A; Zhong C; Simler G; Zhan C; Bratcher N; Boyce-Rustay JM; Zhu CZ; Bhatia P; Doherty G; Mack H; Stewart AO; Jarvis MF
Biochem Pharmacol; 2012 Feb; 83(3):406-18. PubMed ID: 22153861
[TBL] [Abstract][Full Text] [Related]
2. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
[TBL] [Abstract][Full Text] [Related]
4. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
[TBL] [Abstract][Full Text] [Related]
5. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
Todorovic SM; Pathirathna S; Brimelow BC; Jagodic MM; Ko SH; Jiang X; Nilsson KR; Zorumski CF; Covey DF; Jevtovic-Todorovic V
Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
[TBL] [Abstract][Full Text] [Related]
6. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into the analgesic efficacy of A-1264087, a novel neuronal Ca(2+) channel blocker that reduces nociception in rat preclinical pain models.
Zhu CZ; Vortherms TA; Zhang M; Xu J; Swensen AM; Niforatos W; Neelands T; Milicic I; Lewis LG; Zhong C; Gauvin D; Mikusa J; Zhan C; Pai M; Roderwald V; Chu KL; Cole EE; Bespalov A; Searle XB; McGaraughty S; Bitner RS; Jarvis MF; Bannon AW; Joshi SK; Scott VE; Lee CH
J Pain; 2014 Apr; 15(4):387.e1-14. PubMed ID: 24374196
[TBL] [Abstract][Full Text] [Related]
8. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
[TBL] [Abstract][Full Text] [Related]
9. A mixed Ca2+ channel blocker, A-1264087, utilizes peripheral and spinal mechanisms to inhibit spinal nociceptive transmission in a rat model of neuropathic pain.
Xu J; Chu KL; Zhu CZ; Niforatos W; Swensen A; Searle X; Lee L; Jarvis MF; McGaraughty S
J Neurophysiol; 2014 Jan; 111(2):394-404. PubMed ID: 24155005
[TBL] [Abstract][Full Text] [Related]
10. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
Matthews EA; Bee LA; Stephens GJ; Dickenson AH
Eur J Neurosci; 2007 Jun; 25(12):3561-9. PubMed ID: 17610575
[TBL] [Abstract][Full Text] [Related]
11. Modulation of N-type calcium currents by presynaptic imidazoline receptor activation in rat superior cervical ganglion neurons.
Chung S; Ahn DS; Kim YH; Kim YS; Joeng JH; Nam TS
Exp Physiol; 2010 Oct; 95(10):982-93. PubMed ID: 20696781
[TBL] [Abstract][Full Text] [Related]
12. Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide.
Todorovic SM; Jevtovic-Todorovic V; Mennerick S; Perez-Reyes E; Zorumski CF
Mol Pharmacol; 2001 Sep; 60(3):603-10. PubMed ID: 11502893
[TBL] [Abstract][Full Text] [Related]
13. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons.
Wu ZZ; Chen SR; Pan HL
Neuroscience; 2006 Aug; 141(1):407-19. PubMed ID: 16678970
[TBL] [Abstract][Full Text] [Related]
14. Spinal antinociception of synthetic omega-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium channel blocker, and its effects on morphine analgesia in chemical stimulus tests in rodent.
Yan LD; Liu YL; Zhang L; Dong HJ; Zhou PL; Su RB; Gong ZH; Huang PT
Eur J Pharmacol; 2010 Jun; 636(1-3):73-81. PubMed ID: 20361956
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive action of myricitrin: involvement of the K+ and Ca2+ channels.
Meotti FC; Fachinetto R; Maffi LC; Missau FC; Pizzolatti MG; Rocha JB; Santos AR
Eur J Pharmacol; 2007 Jul; 567(3):198-205. PubMed ID: 17467689
[TBL] [Abstract][Full Text] [Related]
16. High voltage-activated Ca(2+) channel currents in isolectin B(4)-positive and -negative small dorsal root ganglion neurons of rats.
Wu ZZ; Pan HL
Neurosci Lett; 2004 Sep; 368(1):96-101. PubMed ID: 15342142
[TBL] [Abstract][Full Text] [Related]
17. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
18. CSTX-1, a toxin from the venom of the hunting spider Cupiennius salei, is a selective blocker of L-type calcium channels in mammalian neurons.
Kubista H; Mafra RA; Chong Y; Nicholson GM; Beirão PS; Cruz JS; Boehm S; Nentwig W; Kuhn-Nentwig L
Neuropharmacology; 2007 Jun; 52(8):1650-62. PubMed ID: 17517422
[TBL] [Abstract][Full Text] [Related]
19. Mechanical and thermal anti-nociception in rats after systemic administration of verapamil.
Todorovic SM; Pathirathna S; Meyenburg A; Jevtovic-Todorovic V
Neurosci Lett; 2004 Apr; 360(1-2):57-60. PubMed ID: 15082178
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
